Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Clinical Investigation to Evaluate Efficacy and Safety of IQP-AK-102 on Appetite Reduction in Healthy Over- Weight Subjects

NCT02774486 is registered in ClinicalTrials.gov with InQpharm Group as lead sponsor.

NCT NCT02774486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Clinical Investigation to Evaluate Efficacy and Safety of IQP-AK-102 on Appetite Reduction in Healthy Over- Weight Subjects
Lead sponsor
InQpharm Group
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2016
Completion date
July 20, 2016
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appetite regulation, appetite suppression, energy intake